Innoviva, Inc. (INVA): Price and Financial Metrics

INVA POWR Grades

• INVA scores best on the Value dimension, with a Value rank ahead of 97.98% of US stocks.
• INVA's strongest trending metric is Quality; it's been moving up over the last 177 days.
• INVA's current lowest rank is in the Sentiment metric (where it is better than 11.45% of US stocks).

INVA Stock Summary

• With a price/earnings ratio of 3.02, INNOVIVA INC P/E ratio is greater than that of about only 3.94% of stocks in our set with positive earnings.
• Of note is the ratio of INNOVIVA INC's sales and general administrative expense to its total operating expenses; merely 0.31% of US stocks have a lower such ratio.
• For INVA, its debt to operating expenses ratio is greater than that reported by only 0.35% of US equities we're observing.
• If you're looking for stocks that are quantitatively similar to INNOVIVA INC, a group of peers worth examining would be CHK, CRK, EQT, CPG, and WPM.
• Visit INVA's SEC page to see the company's official filings. To visit the company's web site, go to www.inva.com.

INVA Valuation Summary

• In comparison to the median Healthcare stock, INVA's price/earnings ratio is 86.34% lower, now standing at 3.1.
• INVA's EV/EBIT ratio has moved up 10.2 over the prior 223 months.

Below are key valuation metrics over time for INVA.

INVA Growth Metrics

Its 5 year net cashflow from operations growth rate is now at 212.02%.
• Its 4 year net income to common stockholders growth rate is now at 162.61%.
• Its 3 year net cashflow from operations growth rate is now at 50.96%.

INVA's revenue has moved up $112,200,000 over the prior 33 months.

The table below shows INVA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	373.216	291.208	292.58
2022-06-30	403.821	372.229	99.495
2022-03-31	396.407	377.808	187.504
2021-12-31	391.866	363.813	265.854
2021-12-31	391.866	363.813	265.854
2021-09-30	374.662	350.712	309.412

INVA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• INVA has a Quality Grade of B, ranking ahead of 77.13% of graded US stocks.
• INVA's asset turnover comes in at 0.398 -- ranking 118th of 682 Pharmaceutical Products stocks.
• LUMO, RETA, and SUPN are the stocks whose asset turnover ratios are most correlated with INVA.

The table below shows INVA's key quality metrics over time.